Related references
Note: Only part of the references are listed.Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge
V. Balloy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Reactivation of Multiple Viruses in Patients with Sepsis
Andrew H. Walton et al.
PLOS ONE (2014)
Sirolimus for Treatment of Autosomal-Dominant Polycystic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials
Y. -M. Liu et al.
TRANSPLANTATION PROCEEDINGS (2014)
Blood, Tissue, and Intracellular Concentrations of Azithromycin during and after End of Therapy
P. Matzneller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Reduction of Immunocompetent T Cells Followed by Prolonged Lymphopenia in Severe Sepsis in the Elderly
Shigeaki Inoue et al.
CRITICAL CARE MEDICINE (2013)
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis
Cinzia Dello Russo et al.
GLIA (2013)
Preventing COPD exacerbations with macrolides: A review and budget impact analysis
Steven Simoens et al.
RESPIRATORY MEDICINE (2013)
Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
Guy G. Brusselle et al.
THORAX (2013)
Comparison of the Effect of Standard and Novel Immunosuppressive Drugs on CMV-Specific T-Cell Cytokine Profiling
Adrian Egli et al.
TRANSPLANTATION (2013)
Azithromycin distinctively modulates classical activation of human monocytes in vitro
M. Vrancic et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients
Gundeep S. Dhillon et al.
CLINICAL TRANSPLANTATION (2012)
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases
P. Zarogoulidis et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Severe sepsis in community-acquired pneumonia - Early recognition and treatment
Jose Manuel Pereira et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
Conroy Wong et al.
LANCET (2012)
Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics
Helen C. Steel et al.
MEDIATORS OF INFLAMMATION (2012)
mTOR Regulates T-Cell Differentiation and Activation in Immunity and Autoimmunity
Yujing Bi et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2011)
Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia
Martina Bosnar et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Jonathan S. Boomer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Bet v 1-specific T-cell receptor/forkhead box protein 3 transgenic T cells suppress Bet v 1-specific T-cell effector function in an activation-dependent manner
Klaus G. Schmetterer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Azithromycin suppresses proliferation, interleukin production and mitogen-activated protein kinases in human peripheral-blood mononuclear cells stimulated with bacterial superantigen
Yoko Hiwatashi et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Azithromycin for Prevention of Exacerbations of COPD
Richard K. Albert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
New perspectives on immunomodulatory therapy for bacteraemia and sepsis
Steven M. Opal
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
A trial of clarithromycin for the treatment of suboptimally controlled asthma
E. Rand Sutherland et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Azithromycin reduces the viability of human bronchial smooth muscle cells
Rodopi Stamatiou et al.
JOURNAL OF ANTIBIOTICS (2010)
T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells
Judith Leitner et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Transforming growth factor beta 1 (TGF-β1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs
Koichi Kawamoto et al.
TRANSPLANT IMMUNOLOGY (2010)
Macrolides in the treatment of bronchiolitis obliterans in allograft recipients
N. Maimon et al.
BONE MARROW TRANSPLANTATION (2009)
Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels
Wen Qiang Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor
L. Zhao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Ketolides - The Modern Relatives of Macrolides The Pharmacokinetic Perspective
Markus Zeitlitzger et al.
CLINICAL PHARMACOKINETICS (2009)
Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells
R. Stamatiou et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Macrolides, Ketolides, and Glycylcyclines: Azithromycin, Clarithromycin, Telithromycin, Tigecycline
Jerry M. Zuckerman et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Azithromycin Reduces Tumor Necrosis Factor-Alpha Production in Lipopolysaccharide-Stimulated THP-1 Monocytic Cells by Modification of Stress Response and p38 MAPK Pathway
S. Ikegaya et al.
JOURNAL OF CHEMOTHERAPY (2009)
Cytomegalovirus infection in critically ill patients: a systematic review
Ryosuke Osawa et al.
CRITICAL CARE (2009)
Clarithromycin targets neutrophilic airway inflammation in refractory asthma
Jodie L. Simpson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Immunomodulatory therapies for sepsis: unexpected effects with macrolides
Evangelos J. Giamarellos-Bourboulis
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation
Jens Gottlieb et al.
TRANSPLANTATION (2008)
mTOR at the crossroads of T cell proliferation and tolerance
Anna Mondino et al.
SEMINARS IN IMMUNOLOGY (2007)
Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen
Ping Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells
B. M. Vanaudenaerde et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Sirolimus - Challenging current perspectives
Irina Buhaescu et al.
THERAPEUTIC DRUG MONITORING (2006)
Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE)
B Asquith et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
The bacterial ribosome as a target for antibiotics
J Poehlsgaard et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Differential effects of three antibiotics on T helper cell cytokine expression
AC Williams et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Antibiotic-induced apoptosis in human activated peripheral lymphocytes
JI Kadota et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD
D Banerjee et al.
RESPIRATORY MEDICINE (2005)
Macrolides for the treatment of chronic sinusitis, asthma, and COPD
MH Gotfried
CHEST (2004)
Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL
S Mizunoe et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
Macrolide antibiotics induce apoptosis of human peripheral lymphocytes in vitro
Y Ishimatsu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis
MJ Schultz
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance
G Roth et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
T cell receptor signaling precedes immunological synapse formation
KH Lee et al.
SCIENCE (2002)
Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial
J Wolter et al.
THORAX (2002)
Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes
WL Hand et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers
GW Amsden et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Share Paper
